Dyspepsia surgery

Jump to navigation Jump to search

Dyspepsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dyspepsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dyspepsia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dyspepsia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dyspepsia surgery

CDC on Dyspepsia surgery

Dyspepsia surgery in the news

Blogs on Dyspepsia surgery

Directions to Hospitals Treating Dyspepsia

Risk calculators and risk factors for Dyspepsia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]

Overview

Surgery for dyspepsia is reserved for a small but important subset of patients with well-defined structural disease — principally peptic ulcer disease complicated by perforation, haemorrhage, obstruction, or medical intractability — and, in highly selected cases, for medically refractory symptoms attributable to disordered gastric neuromuscular function. Critically, contemporary guidelines from the British Society of Gastroenterology (BSG) explicitly state that surgery should be avoided in patients with severe or refractory FD, in order to minimise iatrogenic harm, given the absence of high-quality evidence for benefit and the recognized risk of worsening symptoms post-operatively.[1] The substantial reduction in elective peptic ulcer surgery over recent decades is directly attributable to the discovery of Helicobacter pylori and the development of effective proton pump inhibitor (PPI) and eradication therapies.

Surgery

Surgical intervention in dyspepsia is predominantly indicated for organic complications of peptic ulcer disease rather than for FD per se. Recognised indications include:

Indication Clinical Scenario Preferred Approach
Perforated peptic ulcer Pneumoperitoneum, peritonitis, haemodynamic instability Laparoscopic or open repair; omental patch closure
Upper gastrointestinal bleeding refractory to endoscopy Failure of repeated endoscopic haemostasis Open or laparoscopic gastric surgery; angiographic embolization if available
Gastric outlet obstruction Pyloric stenosis secondary to chronic PUD; vomiting, succussion splash Gastrojejunostomy, vagotomy and drainage, or endoscopic dilatation where feasible
Intractable peptic ulceration Failure of maximal medical therapy including PPI and H. pylori eradication, confirmed absence of NSAID use Highly selective vagotomy (preferred elective procedure), or vagotomy and drainage
Suspected or confirmed gastric cancer Ulcer with malignant features on endoscopy/histology Gastrectomy with curative or palliative intent
Medically refractory gastroparesis with dyspeptic symptoms Objective delayed gastric emptying (>10% retention at 4 h), failure of dietary and pharmacological management Gastric electrical stimulation (GES), laparoscopic pyloroplasty, or G-POEM

References

  1. Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S, Winning RC, Corsetti M, Ford AC. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut. 2022 Sep;71(9):1697-1723. doi: 10.1136/gutjnl-2022-327737. Epub 2022 Jul 7. PMID: 35798375; PMCID: PMC9380508.

Template:WS Template:WH